Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $143.92M in the quarter ending September 30, 2026, with 45.05% growth. This brings the company's total for the last twelve months to $508.68M, up 60.00% year-over-year. In the year 2025, Arcutis Biotherapeutics had annual revenue of $376.07M with 91.34% growth. That makes Arcutis Biotherapeutics the 11,178th largest company in the world by revenue and 2,286th in the United States.

• Revenue (ttm): $508.68M
• Revenue Growth: +60.00%
• P/S Ratio: 6.37
• Revenue / Employee: $1,436,952
• Employees: 354
• Market Cap: 3.22B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• ZORYVE Foam 181.89M 48.4%
• ZORYVE Cream 0.3% 121.00M 32.2%
• ZORYVE Cream 0.15% 68.27M 18.2%
• Other Segment 4.00M 1.1%
• ZORYVE Cream 0.05% 911.00K 0.2%

Fiscal year ended Dec 31, 2025 See the full Arcutis Biotherapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	376.07M	179.53M	91.34%
Dec 31, 2024	196.54M	136.94M	229.74%
Dec 31, 2023	59.61M	55.92M	1,517.09%
Dec 31, 2022	3.69M	-	-
Dec 31, 2021	-	-	-

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error